The prognostic value of pro-B-Type natriuretic peptide in acute pulmonary embolism

Thrombosis Research

Volumn 131, Issue 6, 2013, Pages

  Verschuren, Franck ^a   Bonnet, Mathieu ^a   Benoit, Marie Odile ^c   Gruson, Damien ^a   Zech, Francis ^a   Couturaud, Francis ^d   Meneveau, Nicolas ^e   Roy, Pierre Marie ^f   Righini, Marc ^g   Meyer, Guy ^b   Sanchez, Olivier ^b  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d UNIVERSITÉ EUROPÉENNE DE BRETAGNE   (France)

^e UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^f ANGERS UNIVERSITY HOSPITAL   (France)

^g GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Biomarkers; Natriuretic peptides; Prognosis; Pulmonary embolism

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CARDIOGENIC SHOCK; CLINICAL EXAMINATION; DEATH; ECHOCARDIOGRAPHY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; KIDNEY FAILURE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; VENOUS THROMBOEMBOLISM;

ACUTE DISEASE; AGED; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; PULMONARY EMBOLISM; ROC CURVE;

EID: 84878859072     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.03.009     Document Type: Article

References (24)

1. P.M. Roy, G. Meyer, B. Vielle, C. Le Gall, F. Verschuren, and F. Carpentier Appropriateness of diagnostic management and outcomes of suspected pulmonary embolism Ann Intern Med 144 2006 157 164
2. S.A. Ibrahim, R.A. Stone, D.S. Obrosky, M. Geng, M.J. Fine, and D. Aujesky Thrombolytic therapy and mortality in patients with acute pulmonary embolism Arch Intern Med 168 2008 2183 2190
3. O. Sanchez, L. Trinquart, I. Colombet, P. Durieux, M.V. Huisman, and G. Chatellier Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review Eur Heart J 29 2008 1569 1577
4. A. Schellhaass, A. Walther, S. Konstantinides, and B.W. Böttiger The diagnosis and treatment of acute pulmonary embolism Dtsch Arztebl Int 107 Aug 2010 589 595
5. V. Snow, A. Qaseem, P. Barry, E.R. Hornbake, J.E. Rodnick, and T. Tobolic Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians Ann Intern Med 146 2007 204 210
6. A. Torbicki, A. Perrier, S. Konstantinides, G. Agnelli, N. Galiè, and P. Pruszczyk ESC Committee for Practice Guidelines (CPG). Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Eur Heart J 29 2008 2276 2315
7. S.Z. Goldhaber, L. Visani, and M. De Rosa Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) Lancet 353 1999 1386 1389
8. Steering Committee Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury: Rationale and design of the Pulmonary Embolism Thrombolysis (PEITHO) trial Am Heart J 163 2012 33 38
9. L. Masotti, M. Righini, N. Vuilleumier, F. Antonelli, G. Landini, and R. Cappelli Prognostic stratification of acute pulmonary embolism: focus on clinical aspects, imaging, and biomarkers Vasc Health Risk Manag 5 2009 567 575
10. N. Vuilleumier, G. Le Gal, F. Verschuren, A. Perrier, H. Bounameaux, and N. Turck Cardiac biomarkers for risk stratification in non-massive pulmonary embolism: a multicenter prospective study J Thromb Haemost 7 2009 391 398
11. C. Becattini, M.C. Vedovati, and G. Agnelli Prognostic value of troponins in acute pulmonary embolism: a meta-analysis Circulation 116 2007 427 433
12. F.A. Klok, I.C. Mos, and M.V. Huisman Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and meta-analysis Am J Respir Crit Care Med 178 2008 425 430
13. O. Sanchez, L. Trinquart, V. Caille, F. Couturaud, G. Pacouret, and N. Meneveau Prognostic factors for Pulmonary embolism The PREP study, A prospective muticenter cohort study Am J Respir Crit Care Med 181 2010 168 173
14. S.W. Waldo, J. Beede, S. Isakson, S. Villard-Saussine, J. Fareh, and P. Clopton Pro-B-type natriuretic peptide levels in acute decompensated heart failure J Am Coll Cardiol 51 2008 1874 1882
15. C.S. Lam, J. Burnett, L. Costello-Boerrigter, R.J. Rodeheffer, and M.M. Redfield Alternate circulating Pro-B-type natriuretic peptide and B-type natriuretic petide forms in the general population J Am Coll Cardiol 49 2007 1193 1202
16. A.J. Burnham, J.F. Macgregor, and R. Viveros A statistical framework for multivariate latent variable regression methods based on maximum likelihood J Chemom 13 1999 49 65
17. M.T. Lee, and B.A. Rosner The average area under correlated receiver operating characteristic curves: a non parametric approach based on generalized two-sample Wilcoxon statistics Appl Stat 50 2001 337 344
18. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172
19. D. Aujeski, P.M. Roy, F. Verschuren, M. Righini, J. Osterwalder, and M. Egloff Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial Lancet 378 2011 41 48
20. K.N. Luckenbill, R.H. Christenson, A.S. Jaffe, J. Mair, J. Ordonez-Llanos, and F. Pagani Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NTproBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage Clin Chem 54 2008 619 621
21. I. Giuliani, F. Rieunier, C. Larue, J.F. Delagneau, C. Granier, and B. Pau Assay for measurement of intact B-type natriuretic peptide prohormone in blood Clin Chem 52 2006 1054 1061
22. M. Emdin, C. Passino, and A. Clerico Natriuretic peptide assays revisited: do we need pro-B-type natriuretic peptide? J Am Coll Cardiol 57 2011 1396 1398
23. S. Krüger, J. Graf, M.W. Merx, K.C. Koch, D. Kunz, and P. Hanrath Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism Am Heart J 147 2004 60 65
24. N. Vuilleumier, G. Le Gal, J.C. Cornily, D. Hochstrasser, H. Bounameaux, and D. Aujesky Is N-terminal pro-brain natriuretic peptide superior to clinical scores for risk stratification in non-massive pulmonary embolism? J Thromb Haemost 8 2010 1433 1435